A morphological analysis did not imply that the myeloma-like phenotype is related to previously known biological risk factors for this patient group, such as tumour cell proliferation, AR activity, bone remodelling, or the recently described metastasis subclasses MetA, MetB, and MetC [14]. The gene discussed is AR; the disease is plasma cell myeloma.